|
Dr. Rafik Karaman: Prodrugs Targeting the Central Nervous System (CNS)
|
Hits: 1646
|
|
Dr. Rafik Karaman: Antibacterial Predrugs-from 1899 till 2015
|
Hits: 1849
|
|
Dr. Rafik Karaman: Design, Synthesis and In-vitro Kinetic Study of Atovaquone Prodrug for the Treatment of Malaria
|
Hits: 1757
|
|
Dr. Rafik Karaman: Antibacterial Activity of Novel Prodrugs of Amoxicillin and Cephalexin
|
Hits: 1726
|
|
Dr. Rafik Karaman: Probing the binding pocket of the broadly tuned human bitter taste receptor TAS2R14 by chemical modification of cognate agonists
|
Hits: 1523
|
|
Dr. Rafik Karaman: Recent updates in utilizing prodrugs in drug delivery (2013-2015)
|
Hits: 1581
|
|
Dr. Rafik Karaman: Design, Synthesis, Characterization and In-Vitro Kinetic Study of Novel Antibacterials Prodrugs
|
Hits: 1870
|
|
Dr. Rafik Karaman Removal of Two NSAIDs: Naproxen and Diclofenac and a Heavy Metal Cr (VI) by Advanced Membranes Technology
|
Hits: 2581
|
|
Dr. Omar Deeb: Homology modeling, molecular dynamics and docking simulations of rat A2A receptor: a three-dimensional model validation under QSAR studies
|
Hits: 3259
|
|
Dr. Omar Deeb: Homology modeling, molecular dynamics and docking simulations of rat A2A receptor: a three-dimensional model validation under QSAR studies
|
Hits: 2324
|
